Navigation Links
'First-in-human' drug for malignant glioma available in experimental trial
Date:2/15/2012

CINCINNATI -- The UC Cancer Institute is one of three centers internationally approved to test an experimental drug's safety and pharmacokinetics and also assess the clinical benefit against recurrent malignant glioma, an aggressive form of brain cancer.

The "first-in-human" phase-1 trial is expected to enroll up to 60 patients at clinical sites in the United States and Australia.

Led by Olivier Rixe, MD, PhD, this experimental drug trial uses antibody-drug conjugate (ADC) technology, a new drug delivery concept currently being investigated in the treatment of various cancers. ADC molecules consist of an antibody linked to a specific cytotoxic drug that is intended to target, bind and disperse only in malignant cells.

The experimental drug (called AMG 595) is intended to target a specific mutated cell receptor (EGFRvIII) which exists on the surface of tumor cells in up to 30 percent of patients with malignant gliomas. Preliminary studies in animals have shown that ADC molecules can effectively find these specific cancer cells, then enter them and release an active cytotoxic agent with the aim of killing the tumor cells while minimizing damage to the surrounding normal tissue.

"This allows us to use a highly cytotoxic drug targeted to the cancer cells in the brain based on a specific cellular marker," explains Rixe, John and Gladys Strauss Chair in Cancer Research at the UC College of Medicine and director of the Experimental Therapeutics/Phase 1 Clinical Trials Program. "Until recently, primary brain tumor patients have traditionally been excluded from phase-1 oncology studies, so finding drugs to effectively target and make real advances against this particular type of very aggressive cancer has been virtually impossible."

Patients who have failed first- and second-line therapies for malignant glioma may qualify to participate in this trial. Potential candidates will be screened for the EGFRvIII mutation using t
'/>"/>

Contact: Amanda Harper
amanda.harper@uc.edu
513-558-4657
University of Cincinnati Academic Health Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Cancer-targeting investigational nanoparticle receives FDA IND approval for first-in-human trial
2. Using Viagra to combat malignant melanoma
3. Elusive gene mutations found for malignant brain tumor
4. Agent selectively targets malignant B cells in chronic leukemia, study shows
5. Malignant brain tumors: Benefit of PET and PET/CT in the detection of recurrences is not assessable
6. Huge pelvi-abdominal malignant inflammatory myofibroblastic tumor
7. Novel RNA interference screening technique identifies possible path for malignant glioma treatment
8. CD97 gene expression and function correlate with WT1 protein expression and glioma invasiveness
9. RTOG activates study to determine best treatment strategies for patients with glioma brain tumors
10. Photons vs. protons for treatment of spinal cord gliomas
11. Discordance among commercially-available diagnostics for latent TB infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... ... the recent report by JAMA Internal Medicine published on June 22, 2015, ... declared a war on obesity in the United States. , "Obesity is one of ... magnitude of this discovery. For that reason, I am declaring, along with my Health ...
(Date:7/2/2015)... ... July 02, 2015 , ... In 2012, Patrick Achebe realized that the gift of poetry was ... down to write his first poem, and three years later he was publishing an entire ... worth sharing with the world. "I have always believed that the best way to lift ...
(Date:7/2/2015)... ... ... Six months ahead of his 80th birthday, Don Stevenson has reached the ... the Pulmonary Hypertension Association (PHA). Stevenson began the walk in Washington State three ... He left Glasgow, Mont. yesterday morning and is making his way to Wolf Point. ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... M.D., to the orthopedic and spine surgery team at their Anaheim clinic. Dr. ... and tendonitis. Along with the spine and spine surgery, Dr. Krishnareddy also specializes ...
(Date:7/2/2015)... ... July 02, 2015 , ... Octo Consulting Group, (Octo), ... federal government, has announced they are among nine contractors awarded the U.S. Securities ... (BMOSS) contract not to exceed $250 million. , To achieve the goals ...
Breaking Medicine News(10 mins):Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 2Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 3Health News:Octo Consulting Group Awarded IDIQ Contract for SEC Business Management Support 2
... National ... Immunization Awareness Month, NORTH HAVEN, Conn., Sept. 6 In ... in,Connecticut is reminding parents to make sure their adolescents,immunizations are up ... the perfect time for parents to check with their child,s provider,to ...
... Hospital Directory show new rules issued by the Centers, for ... rural hospitals and hospitals specializing in cardiac care. ... changes in outlier payment are also forecasted., ... Services (CMS) has issued the most sweeping rule,changes for hospital ...
... IV product a proven treatment -, BELLEVILLE, ... (TSX: BNC), a research-based, technology-driven Canadian,biopharmaceutical company, today ... to Australia in order to be able to ... that continent,s equine influenza outbreak.,The outbreak began in ...
... of women with breast cancer stopped taking a commonly ... to a new study from researchers at the University ... the study were taking aromatase inhibitors, a type of ... fuels some breast cancers. The treatment is generally given ...
... LOUISVILLE, Ky., Sept. 5 Ventas, Inc. (NYSE:,VTR) ("Ventas" ... Directors,declared a regular quarterly dividend of $0.475 per share, ... record on September 17, 2007. The,dividend is the third ... dividend. Ventas, Inc. is a leading healthcare real ...
... a,wholly owned subsidiary of Siemens Corporation, announced today that ... offer for all outstanding,shares of common stock of Dade ... has been extended to 12:00 Midnight, New York City ... being made pursuant to,an Agreement and Plan of Merger, ...
Cached Medicine News:Health News:Immunizations Part of Back to School Preparations 2Health News:Immunizations Part of Back to School Preparations 3Health News:Just Completed Studies Reveal Impact of New Medicare Reimbursement Regulations 2Health News:Bioniche Responds to Australian Equine Influenza Outbreak 2Health News:Bioniche Responds to Australian Equine Influenza Outbreak 3Health News:13 percent of women stop taking breast cancer drug because of side effects, U-M study finds 2Health News:13 percent of women stop taking breast cancer drug because of side effects, U-M study finds 3Health News:Ventas Declares Regular Quarterly Dividend of $0.475 Per Share 2Health News:Ventas Declares Regular Quarterly Dividend of $0.475 Per Share 3Health News:Ventas Declares Regular Quarterly Dividend of $0.475 Per Share 4Health News:Siemens Extends Tender Offer for Acquisition of Dade Behring 2
(Date:7/2/2015)... The report "Silage Inoculants & ... Pediococcus & Enterococcus), Enzymes (Fibre-digesting & Starch-digesting), Crop-type & ... Inoculants & Enzymes Market is expected to reach $489.05 ... 2015 to 2020. Browse 75 market ... P ages and an in-depth TOC ...
(Date:7/2/2015)... -- Konica Minolta, Inc. (Konica Minolta) ( Tokyo ... Technologica Ltda., an X-ray system equipment manufacturer based in ... Brazilian healthcare sales company, Konica Minolta Healthcare do ... Brazil market investment and growth With ... significant healthcare technical advancements and efficiencies are required. Aging ...
(Date:7/2/2015)... de julio de 2015 BGI anunció hoy ... alto rendimiento en Hong Kong ... Pathologists (CAP). La instalación de BGI en Hong ... de próxima generación que recibe la certificación CAP en ... estándar en prácticas de laboratorio clínico. Junto con el ...
Breaking Medicine Technology:Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3BGI recibe la acreditación del College of American Pathologists (CAP) 2
... 2, 2012  Hill-Rom Holdings, Inc. (NYSE: HRC ) ... fiscal year 2012 third quarter dividend of $0.125 per share. ... of record as of the close of business on June ... Hill-Rom is a leading worldwide manufacturer and provider ...
... free Electronic Medical Record ( EMR ) company, today announced ... laboratory in the country to connect directly to the EMR. ... health sector – enables rapid deployment of new laboratory connections ... over 150,000 medical professionals easy access to their local commercial, ...
Cached Medicine Technology:Practice Fusion Launches API to Democratize Lab Integrations 2Practice Fusion Launches API to Democratize Lab Integrations 3
... for convenient pH catheter calibration., ,pH catheters ... procedure. The Alpine Calibration kit contains disposable ... for your convenience. Simply cut the end ... to soak. No measuring or pouring! Available ...
Bravo Datalink. For upload of Bravo pH data to a PC. Connects to the pcs serial port....
Bravo Tubing/Filter Supplies (Ten tubing sets, ten filters)...
Stand with buffer tubes for calibration of Bravo pH capsule....
Medicine Products: